Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes

By R. Abramof. 2012

1,267 citations recorded by the source corpus.

Subfields: Pharmacy, Physiology, Surgery

View Paper: https://www.semanticscholar.org/paper/a03a41eb04a73bcf07fee5dabfcd98a7de5cde8e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pharmacy

1. Steven B. Heymsfield
2. F. B. Hu
3. R. Kushner
4. C. Apovian
5. T. Wadden
6. J. Vincent

In Physiology

1. F. B. Hu
2. Steven B. Heymsfield
3. C. Apovian
4. T. Wadden
5. M. Blüher

In Surgery

1. Steven B. Heymsfield
2. F. B. Hu
3. Judith Hochman
4. T. Wadden

Citations in the corpus

• 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013, background): “the efficacy and predictors searches that included complication data,(141,156) as well as those studies that met the expanded search criteria.(139,143,145,146,152,153,160,170,171)”
• Pharmacological management of obesity: an endocrine Society clinical practice guideline. (2015, neutral): “T2DM Yes Cohen, 2012 (132); Mingrone, 2012 (133); Schauer, 2012 (134); Buchwald, 2009 (135) Hypertension Yes Ilane-Parikka, 2008 (136); Phelan, 2007 (137); Zanella, 2006 (138) Dyslipidemia and metabolic syndrome Yes Ilane-Parikka, 2008 (136); Phelan, 2007 (137); Zanella, 2006 (138) Cardiovascular di”
• Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes (2017, background): “Intravenous treatment for dehydration 3 (7) 7 (14) 4 (8)”
• Health Benefits of Gastric Bypass Surgery after 6 Years (2012, neutral): “Incidence Diabetes 0/299 0 (0-0) 7/290 2 (0-4) 12/255 5 (1-9) 36/207 17 (10-24) 14/213 7 (2-12) 31/207 15 (9-21)”
• Mechanisms, Pathophysiology, and Management of Obesity (2017, methodology): “medical therapy and a lifestyle intervention (MT/LI) as compared with MT/LI alone,(46) Roux-en-Y gastric bypass (RYGB) combined with medical therapy and an intensive lifestyle intervention (MT/ILI) as compared with MT/ILI alone,(75) and vertical-sleeve gastrectomy (VSG) or RYGB combined with MT/LI a”
• 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. (2014, background): “The complication evidence base included those studies from the efficacy and predictors searches that included complication data (141,156), as well as those studies that met the expanded search criteria (139,143,145,146,152,153,160,170,171).”